Notícias Satellos Bioscience Inc - MSCL | Ações Toronto Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Canadá
TSX
Satellos Bioscience Inc (MSCL)
Satellos Bioscience Inc (MSCL) Notícias

Satellos Bioscience Inc (MSCL)

0,73

-0,01

(-1,35%)

Fechado 17 Fevereiro 6:12PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers

Satellos to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247

Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024

Satellos Appoints Stephanie Brown to Board of Directors

Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

Satellos to Participate in November 2024 Investor Conferences

Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels

Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247

Satellos Announces Participation in September 2024 Investor Conferences

Satellos Announces Acceptance of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

Satellos Announces Q2 2024 Financial Results and Updated Canine Data

Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Satellos Bioscience

Eib Tf 11% Ap26 Try

BNP Paribas Issuance

Sparebank 1 Ringerike Ha...

ProShares Ultra Energy

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições